Johnson Matthey PLC (LON:JMAT – Get Free Report) insider Liam Condon purchased 10 shares of the company’s stock in a transaction that occurred on Wednesday, November 11th. The stock was acquired at an average cost of GBX 2,433 per share, for a total transaction of £243.30.
Liam Condon also recently made the following trade(s):
- On Friday, September 11th, Liam Condon purchased 10,951 shares of Johnson Matthey stock. The shares were bought at an average price of GBX 2,306 per share, with a total value of £252,530.06.
Johnson Matthey Stock Up 1.2%
JMAT traded up GBX 28 during midday trading on Wednesday, reaching GBX 2,428. 275,418 shares of the company were exchanged, compared to its average volume of 1,903,049. The company has a debt-to-equity ratio of 69.69, a quick ratio of 0.76 and a current ratio of 1.56. The company’s fifty day moving average price is GBX 2,382.13 and its 200 day moving average price is GBX 2,155.77. The company has a market cap of £3.01 billion, a price-to-earnings ratio of -31.84, a price-to-earnings-growth ratio of 49,242.50 and a beta of 0.88. Johnson Matthey PLC has a one year low of GBX 2,192 and a one year high of GBX 3,245.33.
Analyst Ratings Changes
Several equities research analysts recently issued reports on JMAT shares. Jefferies Financial Group reiterated a “buy” rating and set a GBX 2,330 price target on shares of Johnson Matthey in a report on Tuesday, August 4th. Berenberg Bank raised their price objective on Johnson Matthey from GBX 2,300 to GBX 2,550 and gave the company a “buy” rating in a research note on Wednesday, October 28th. Four investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to MarketBeat.com, Johnson Matthey presently has an average rating of “Moderate Buy” and a consensus target price of GBX 2,370.
Read Our Latest Report on JMAT
Johnson Matthey Company Profile
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.
Recommended Stories
- Five stocks we like better than Johnson Matthey
- Can Constellation Energy’s Contracts Power a Stock Rebound?
- Why Apple Stock Looks Like a Safe Haven After the Midterms
- IonQ Raised the Bar, But 3 Quantum Rivals Face Tough Questions
- On Holding’s Sell-Off Overlooks a Key Part of Its Earnings Story
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.
